LINKINVAX Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for LINKINVAX with the United States Patent and Trademark Office. The USPTO has given the LINKINVAX trademark a serial number of 79333343. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by 4A CONSULTING & ENGINEERING. The LINKINVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological diseases, metabolic diseases, endocrine diseases, eye diseases, ear, nose, and throat diseases, ear diseases, respiratory diseases, digestive system diseases, genito-urinary diseases, traumatic lesions, poisonings, cancers; vaccines; chemical preparations in the nature of medical preparations for medical use, namely, for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological diseases, metabolic diseases, endocrine diseases, eye diseases, ear, nose, and throat diseases, ear diseases, respiratory diseases, digestive system diseases, genito-urinary diseases, traumatic lesions, poisonings, cancers; chemical preparations in the nature of pharmaceutical preparations for pharmaceutical use, namely, for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological dise...

Pharmaceutical research and development; pharmaceutical research and development in the nature of research, development, engineering and testing in the fields of pharmaceutical products, medicines and vaccines; pharmaceutical research and development in the nature of testing, inspection, research and development of pharmaceutical preparations, medicines and vaccines; pharmaceutical research and development in the nature of research and development services for vaccines and medicines; scientific research and development in the field of biotechnology
linkinvax

General Information


Serial Number79333343
Word MarkLINKINVAX
Filing DateThursday, September 16, 2021
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064400
Registration DateTuesday, May 30, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological diseases, metabolic diseases, endocrine diseases, eye diseases, ear, nose, and throat diseases, ear diseases, respiratory diseases, digestive system diseases, genito-urinary diseases, traumatic lesions, poisonings, cancers; vaccines; chemical preparations in the nature of medical preparations for medical use, namely, for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological diseases, metabolic diseases, endocrine diseases, eye diseases, ear, nose, and throat diseases, ear diseases, respiratory diseases, digestive system diseases, genito-urinary diseases, traumatic lesions, poisonings, cancers; chemical preparations in the nature of pharmaceutical preparations for pharmaceutical use, namely, for the treatment of infectious and parasitic diseases, diseases of viral or bacterial origin, dermatological diseases, metabolic diseases, endocrine diseases, eye diseases, ear, nose, and throat diseases, ear diseases, respiratory diseases, digestive system diseases, genito-urinary diseases, traumatic lesions, poisonings, cancers
Goods and ServicesPharmaceutical research and development; pharmaceutical research and development in the nature of research, development, engineering and testing in the fields of pharmaceutical products, medicines and vaccines; pharmaceutical research and development in the nature of testing, inspection, research and development of pharmaceutical preparations, medicines and vaccines; pharmaceutical research and development in the nature of research and development services for vaccines and medicines; scientific research and development in the field of biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name4A CONSULTING & ENGINEERING
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party Name4A CONSULTING & ENGINEERING
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party Name4A CONSULTING & ENGINEERING
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, September 25, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 1, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 1, 2023FINAL DISPOSITION PROCESSED
Wednesday, August 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, January 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 2, 2022REFUSAL PROCESSED BY IB
Wednesday, July 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 13, 2022REFUSAL PROCESSED BY MPU
Thursday, June 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Saturday, February 19, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB